
“The government is keen for Britain to be at the forefront of the genetic revolution, a potential multibillion-pound industry. Last year David Cameron launched a £100m scheme to map the genomes of up to 100,000 people, saying it would help to save lives by delivering new treatments. Under the scheme, firms would be able to access the information at a cost, but ministers insist that all data will be strictly anonymous. However, material released under the Freedom of Information Act reveals that firms can invoke an appeal process to demand ‘patient-identifiable data’, such as age and postcode.”
Related posts:
The Ghosts of Baha Mar: How a $3.5 Billion Paradise Went Bust
Morgan Stanley begins layoffs in credit division
Cashless Sweden distributes paper leaflets preparing country for war with Russia
Central bank puts the brakes on the bitcoin train in India
Contactless cards' cash limits inop; can be skimmed with nearby phone
Debt crisis: France puts brakes on austerity
Russian Banks Experience Foreign Cash Crunch
Facebook-WhatsApp Deal Haunted by Past Web Merger Flops
Lessons from the drug raid that burned a Georgia toddler
PayPal boss to discuss Bitcoin in keynote address at 2014 trade show
The Stocks China’s Rescue Fund Is Buying
Chinese Leadership Announces New Focus on Green Energy
US bans uncharged cell phones, laptops from some flights
Military Plans to Maintain Power in Egypt after Coup
L.A. County Sheriff Awards Carry Permits to Friends, Donors